Ex-situ liver surgery without veno-venous bypass
AIM：To evaluate the results of hepatic resection with ex-situ hypothermic perfusion and without veno-venous bypass.METHODS：In 3 patients with liver tumor,the degree of the inferior vena cava and/or main hepatic vein involvement was verified when the liver was dissociated in the operation.It was impo...
Saved in:
| Published in | World journal of gastroenterology : WJG Vol. 18; no. 48; pp. 7290 - 7295 |
|---|---|
| Main Author | |
| Format | Journal Article |
| Language | English |
| Published |
United States
Baishideng Publishing Group Co., Limited
28.12.2012
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1007-9327 2219-2840 2219-2840 |
| DOI | 10.3748/wjg.v18.i48.7290 |
Cover
| Abstract | AIM：To evaluate the results of hepatic resection with ex-situ hypothermic perfusion and without veno-venous bypass.METHODS：In 3 patients with liver tumor,the degree of the inferior vena cava and/or main hepatic vein involvement was verified when the liver was dissociated in the operation.It was impossible to resect the tumors by the routine hepatectomy,so the patients underwent ex-situ liver surgery,vein cava replacement and hepatic autotransplantation without veno-venous bypass.All surgical procedures were carried out or supervised by a senior surgeon.A retrospective analysis was performed for the prospectively collected data from patients with liver tumor undergoing ex-situ liver surgery,vein cava replacement and hepatic autotransplantation without veno-venous bypass.We also compared our data with the 9 cases of Pichlmayr＇s group.RESULTS：Three patients with liver tumor were analysed.The first case was a 60-year-old female with a huge haemangioma located in S1,S4,S5,S6,S7 and S8 of liver;the second was a 64-year-old man with cholangiocarcinoma in S1,S2,S3 and S4 and the third one was a 55-year-old man with a huge cholangiocarcinoma in S1,S5,S7 and S8.The operation time for the three patients were 6.6,6.4 and 7.3 h,respectively.The anhepatic phases were 3.8,2.8 and 4.0 h.The volume of blood loss during operation were 1200,3100,2000 mL in the three patients,respectively.The survival periods without recurrence were 22 and 17 mo in the first two cases.As for the third case complicated with postoperative hepatic vein outflow obstruction,emergency hepatic vein outflow extending operation and assistant living donor liver transplantation were performed the next day,and finally died of liver and renal failure on the third day.Operation time（6.7 ± 0.47 h vs 13.7 ± 2.6 h） and anhepatic phase（3.5 ± 0.64 h vs 5.7 ± 1.7 h） were compared between Pichlmayr＇s group and our series（P = 0.78）.CONCLUSION：Ex-situ liver resection and liver autotransplantation has shown a potential for treatment of complicated hepatic neoplasms that are unresectable by traditional procedures. |
|---|---|
| AbstractList | To evaluate the results of hepatic resection with ex-situ hypothermic perfusion and without veno-venous bypass.AIMTo evaluate the results of hepatic resection with ex-situ hypothermic perfusion and without veno-venous bypass.In 3 patients with liver tumor, the degree of the inferior vena cava and/or main hepatic vein involvement was verified when the liver was dissociated in the operation. It was impossible to resect the tumors by the routine hepatectomy, so the patients underwent ex-situ liver surgery, vein cava replacement and hepatic autotransplantation without veno-venous bypass. All surgical procedures were carried out or supervised by a senior surgeon. A retrospective analysis was performed for the prospectively collected data from patients with liver tumor undergoing ex-situ liver surgery, vein cava replacement and hepatic autotransplantation without veno-venous bypass. We also compared our data with the 9 cases of Pichlmayr's group.METHODSIn 3 patients with liver tumor, the degree of the inferior vena cava and/or main hepatic vein involvement was verified when the liver was dissociated in the operation. It was impossible to resect the tumors by the routine hepatectomy, so the patients underwent ex-situ liver surgery, vein cava replacement and hepatic autotransplantation without veno-venous bypass. All surgical procedures were carried out or supervised by a senior surgeon. A retrospective analysis was performed for the prospectively collected data from patients with liver tumor undergoing ex-situ liver surgery, vein cava replacement and hepatic autotransplantation without veno-venous bypass. We also compared our data with the 9 cases of Pichlmayr's group.Three patients with liver tumor were analysed. The first case was a 60-year-old female with a huge haemangioma located in S1, S4, S5, S6, S7 and S8 of liver; the second was a 64-year-old man with cholangiocarcinoma in S1, S2, S3 and S4 and the third one was a 55-year-old man with a huge cholangiocarcinoma in S1, S5, S7 and S8. The operation time for the three patients were 6.6, 6.4 and 7.3 h, respectively. The anhepatic phases were 3.8, 2.8 and 4.0 h. The volume of blood loss during operation were 1200, 3100, 2000 mL in the three patients, respectively. The survival periods without recurrence were 22 and 17 mo in the first two cases. As for the third case complicated with postoperative hepatic vein outflow obstruction, emergency hepatic vein outflow extending operation and assistant living donor liver transplantation were performed the next day, and finally died of liver and renal failure on the third day. Operation time (6.7 ± 0.47 h vs 13.7 ± 2.6 h) and anhepatic phase (3.5 ± 0.64 h vs 5.7 ± 1.7 h) were compared between Pichlmayr's group and our series (P = 0.78).RESULTSThree patients with liver tumor were analysed. The first case was a 60-year-old female with a huge haemangioma located in S1, S4, S5, S6, S7 and S8 of liver; the second was a 64-year-old man with cholangiocarcinoma in S1, S2, S3 and S4 and the third one was a 55-year-old man with a huge cholangiocarcinoma in S1, S5, S7 and S8. The operation time for the three patients were 6.6, 6.4 and 7.3 h, respectively. The anhepatic phases were 3.8, 2.8 and 4.0 h. The volume of blood loss during operation were 1200, 3100, 2000 mL in the three patients, respectively. The survival periods without recurrence were 22 and 17 mo in the first two cases. As for the third case complicated with postoperative hepatic vein outflow obstruction, emergency hepatic vein outflow extending operation and assistant living donor liver transplantation were performed the next day, and finally died of liver and renal failure on the third day. Operation time (6.7 ± 0.47 h vs 13.7 ± 2.6 h) and anhepatic phase (3.5 ± 0.64 h vs 5.7 ± 1.7 h) were compared between Pichlmayr's group and our series (P = 0.78).Ex-situ liver resection and liver autotransplantation has shown a potential for treatment of complicated hepatic neoplasms that are unresectable by traditional procedures.CONCLUSIONEx-situ liver resection and liver autotransplantation has shown a potential for treatment of complicated hepatic neoplasms that are unresectable by traditional procedures. AIM：To evaluate the results of hepatic resection with ex-situ hypothermic perfusion and without veno-venous bypass.METHODS：In 3 patients with liver tumor,the degree of the inferior vena cava and/or main hepatic vein involvement was verified when the liver was dissociated in the operation.It was impossible to resect the tumors by the routine hepatectomy,so the patients underwent ex-situ liver surgery,vein cava replacement and hepatic autotransplantation without veno-venous bypass.All surgical procedures were carried out or supervised by a senior surgeon.A retrospective analysis was performed for the prospectively collected data from patients with liver tumor undergoing ex-situ liver surgery,vein cava replacement and hepatic autotransplantation without veno-venous bypass.We also compared our data with the 9 cases of Pichlmayr＇s group.RESULTS：Three patients with liver tumor were analysed.The first case was a 60-year-old female with a huge haemangioma located in S1,S4,S5,S6,S7 and S8 of liver;the second was a 64-year-old man with cholangiocarcinoma in S1,S2,S3 and S4 and the third one was a 55-year-old man with a huge cholangiocarcinoma in S1,S5,S7 and S8.The operation time for the three patients were 6.6,6.4 and 7.3 h,respectively.The anhepatic phases were 3.8,2.8 and 4.0 h.The volume of blood loss during operation were 1200,3100,2000 mL in the three patients,respectively.The survival periods without recurrence were 22 and 17 mo in the first two cases.As for the third case complicated with postoperative hepatic vein outflow obstruction,emergency hepatic vein outflow extending operation and assistant living donor liver transplantation were performed the next day,and finally died of liver and renal failure on the third day.Operation time（6.7 ± 0.47 h vs 13.7 ± 2.6 h） and anhepatic phase（3.5 ± 0.64 h vs 5.7 ± 1.7 h） were compared between Pichlmayr＇s group and our series（P = 0.78）.CONCLUSION：Ex-situ liver resection and liver autotransplantation has shown a potential for treatment of complicated hepatic neoplasms that are unresectable by traditional procedures. To evaluate the results of hepatic resection with ex-situ hypothermic perfusion and without veno-venous bypass. In 3 patients with liver tumor, the degree of the inferior vena cava and/or main hepatic vein involvement was verified when the liver was dissociated in the operation. It was impossible to resect the tumors by the routine hepatectomy, so the patients underwent ex-situ liver surgery, vein cava replacement and hepatic autotransplantation without veno-venous bypass. All surgical procedures were carried out or supervised by a senior surgeon. A retrospective analysis was performed for the prospectively collected data from patients with liver tumor undergoing ex-situ liver surgery, vein cava replacement and hepatic autotransplantation without veno-venous bypass. We also compared our data with the 9 cases of Pichlmayr's group. Three patients with liver tumor were analysed. The first case was a 60-year-old female with a huge haemangioma located in S1, S4, S5, S6, S7 and S8 of liver; the second was a 64-year-old man with cholangiocarcinoma in S1, S2, S3 and S4 and the third one was a 55-year-old man with a huge cholangiocarcinoma in S1, S5, S7 and S8. The operation time for the three patients were 6.6, 6.4 and 7.3 h, respectively. The anhepatic phases were 3.8, 2.8 and 4.0 h. The volume of blood loss during operation were 1200, 3100, 2000 mL in the three patients, respectively. The survival periods without recurrence were 22 and 17 mo in the first two cases. As for the third case complicated with postoperative hepatic vein outflow obstruction, emergency hepatic vein outflow extending operation and assistant living donor liver transplantation were performed the next day, and finally died of liver and renal failure on the third day. Operation time (6.7 ± 0.47 h vs 13.7 ± 2.6 h) and anhepatic phase (3.5 ± 0.64 h vs 5.7 ± 1.7 h) were compared between Pichlmayr's group and our series (P = 0.78). Ex-situ liver resection and liver autotransplantation has shown a potential for treatment of complicated hepatic neoplasms that are unresectable by traditional procedures. AIM: To evaluate the results of hepatic resection with ex-situ hypothermic perfusion and without veno-venous bypass. METHODS: In 3 patients with liver tumor, the degree of the inferior vena cava and/or main hepatic vein involvement was verified when the liver was dissociated in the operation. It was impossible to resect the tumors by the routine hepatectomy, so the patients underwent ex-situ liver surgery, vein cava replacement and hepatic autotransplantation without veno-venous bypass. All surgical procedures were carried out or supervised by a senior surgeon. A retrospective analysis was performed for the prospectively collected data from patients with liver tumor undergoing ex-situ liver surgery, vein cava replacement and hepatic autotransplantation without veno-venous bypass. We also compared our data with the 9 cases of Pichlmayr’s group. RESULTS: Three patients with liver tumor were analysed. The first case was a 60-year-old female with a huge haemangioma located in S1, S4, S5, S6, S7 and S8 of liver; the second was a 64-year-old man with cholangiocarcinoma in S1, S2, S3 and S4 and the third one was a 55-year-old man with a huge cholangiocarcinoma in S1, S5, S7 and S8. The operation time for the three patients were 6.6, 6.4 and 7.3 h, respectively. The anhepatic phases were 3.8, 2.8 and 4.0 h. The volume of blood loss during operation were 1200, 3100, 2000 mL in the three patients, respectively. The survival periods without recurrence were 22 and 17 mo in the first two cases. As for the third case complicated with postoperative hepatic vein outflow obstruction, emergency hepatic vein outflow extending operation and assistant living donor liver transplantation were performed the next day, and finally died of liver and renal failure on the third day. Operation time (6.7 ± 0.47 h vs 13.7 ± 2.6 h) and anhepatic phase (3.5 ± 0.64 h vs 5.7 ± 1.7 h) were compared between Pichlmayr’s group and our series ( P = 0.78). CONCLUSION: Ex-situ liver resection and liver autotransplantation has shown a potential for treatment of complicated hepatic neoplasms that are unresectable by traditional procedures. |
| Author | Ke-Ming Zhang Xiong-Wei Hu Jia-Hong Dong Zhi-Xian Hong Zhao-Hai Wang Gao-Hua Li Rui-Zhao Qi Wei-Dong Duan Shao-Geng Zhang |
| AuthorAffiliation | Department of Hepatobiliary Surgery, 302 Hospital of Chinese People＇s Liberation Army, Beijing 100039, China Department of Hepatobiliary Surgery, General Hospital of Chinese People＇s LiberationArmy, Beijing 100853, China |
| Author_xml | – sequence: 1 givenname: Ke-Ming surname: Zhang fullname: Zhang, Ke-Ming |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23326135$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9UTtPwzAQtlARfcDOhMLGkmL7nNhZkFBVHhISC8yWmzqpqzRu7aSl_x5XfQgYGOwb7nvc3ddHndrWGqFrgofAmbjfzMvhmoihYWLIaYbPUI9SksVUMNxBPYIxjzOgvIv63s8xpgAJvUDdUGlKIOkhPP6KvWnaqDJr7SLfulK7bbQxzcy2TbTWtY13X-ujyXapvL9E54WqvL461AH6fBp_jF7it_fn19HjW5yDwE2seaYABC0yMk2J4FOi83TCMkhzygtMRegnhCVZMkmmKskLgRlQoVOcAajwBuhhr7tsJws9zXXdOFXJpTML5bbSKiN_d2ozk6VdS0gYw0CDwN1BwNlVq30jF8bnuqpUrcM6klAOKWVhuAC9-el1MjmeKQDSPSB31nunC5mbRjXG7qxNJQmWuzxkyEOGPGTIQ-7yCET8h3jU_odye6DMbF2uTF2eOIxxYJwT-AaPjZnh |
| CitedBy_id | crossref_primary_10_16931_1995_5464_2018445_53 crossref_primary_10_1111_ajt_13465 crossref_primary_10_1016_j_hbpd_2019_07_001 crossref_primary_10_1007_s11605_015_2842_z crossref_primary_10_1002_jhbp_488 crossref_primary_10_1016_S1499_3872_16_60175_3 crossref_primary_10_2217_hep_13_5 crossref_primary_10_1097_JS9_0000000000000604 crossref_primary_10_1245_s10434_017_6104_z crossref_primary_10_3892_ol_2015_3041 crossref_primary_10_1007_s00423_020_01989_7 crossref_primary_10_1016_j_hbpd_2023_10_007 crossref_primary_10_3748_wjg_v23_i20_3702 crossref_primary_10_1097_TP_0000000000004813 crossref_primary_10_3390_jcm10173829 crossref_primary_10_1097_SLA_0000000000000787 crossref_primary_10_1016_j_surg_2018_11_007 crossref_primary_10_1016_j_suc_2015_11_006 crossref_primary_10_1016_j_jhep_2018_07_006 crossref_primary_10_1016_j_surg_2020_05_036 crossref_primary_10_3892_ol_2018_9693 crossref_primary_10_1097_MOT_0000000000000999 crossref_primary_10_1097_SLA_0000000000006505 crossref_primary_10_1007_s00423_021_02093_0 crossref_primary_10_3390_cancers13153735 crossref_primary_10_1016_j_banm_2019_01_003 crossref_primary_10_1016_j_hbpd_2024_12_005 crossref_primary_10_1016_j_surg_2022_04_002 |
| ContentType | Journal Article |
| Copyright | 2012 Baishideng Publishing Group Co., Limited. All rights reserved. 2012 |
| Copyright_xml | – notice: 2012 Baishideng Publishing Group Co., Limited. All rights reserved. 2012 |
| DBID | 2RA 92L CQIGP W91 ~WA AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
| DOI | 10.3748/wjg.v18.i48.7290 |
| DatabaseName | 维普期刊资源整合服务平台 中文科技期刊数据库-CALIS站点 维普中文期刊数据库 中文科技期刊数据库-医药卫生 中文科技期刊数据库- 镜像站点 CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| DocumentTitleAlternate | Ex-situ liver surgery without veno-venous bypass |
| EISSN | 2219-2840 |
| EndPage | 7295 |
| ExternalDocumentID | PMC3544032 23326135 10_3748_wjg_v18_i48_7290 44734771 |
| Genre | Journal Article |
| GroupedDBID | --- 123 29R 2B. 2C~ 2RA 2WC 36B 53G 5VR 8WL 92F 92I 92L 93N 93R AAKDD ACGFO AENEX AFUIB ALMA_UNASSIGNED_HOLDINGS CCEZO CHBEP CIEJG CQIGP CS3 CW9 DIK DU5 E3Z EBS EJD EMB F5P FA0 FRP GX1 HYE M~E OK1 P2P RNS RPM SV3 TCJ TGQ TR2 W91 WFFXF XSB ~WA AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c380t-e79a3382f91d6187d1ec6b4936c27f02879a514595b5da5cf804328e60933a933 |
| ISSN | 1007-9327 2219-2840 |
| IngestDate | Thu Aug 21 13:45:32 EDT 2025 Fri Jul 11 02:28:58 EDT 2025 Thu Apr 03 07:09:51 EDT 2025 Tue Jul 01 03:21:58 EDT 2025 Thu Apr 24 23:00:02 EDT 2025 Wed Feb 14 10:43:56 EST 2024 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | true |
| Issue | 48 |
| Keywords | Liver autotransplantation Liver tumor Total vascular exclusion Ex-situ resection |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c380t-e79a3382f91d6187d1ec6b4936c27f02879a514595b5da5cf804328e60933a933 |
| Notes | 14-1219/R AIM：To evaluate the results of hepatic resection with ex-situ hypothermic perfusion and without veno-venous bypass.METHODS：In 3 patients with liver tumor,the degree of the inferior vena cava and/or main hepatic vein involvement was verified when the liver was dissociated in the operation.It was impossible to resect the tumors by the routine hepatectomy,so the patients underwent ex-situ liver surgery,vein cava replacement and hepatic autotransplantation without veno-venous bypass.All surgical procedures were carried out or supervised by a senior surgeon.A retrospective analysis was performed for the prospectively collected data from patients with liver tumor undergoing ex-situ liver surgery,vein cava replacement and hepatic autotransplantation without veno-venous bypass.We also compared our data with the 9 cases of Pichlmayr＇s group.RESULTS：Three patients with liver tumor were analysed.The first case was a 60-year-old female with a huge haemangioma located in S1,S4,S5,S6,S7 and S8 of liver;the second was a 64-year-old man with cholangiocarcinoma in S1,S2,S3 and S4 and the third one was a 55-year-old man with a huge cholangiocarcinoma in S1,S5,S7 and S8.The operation time for the three patients were 6.6,6.4 and 7.3 h,respectively.The anhepatic phases were 3.8,2.8 and 4.0 h.The volume of blood loss during operation were 1200,3100,2000 mL in the three patients,respectively.The survival periods without recurrence were 22 and 17 mo in the first two cases.As for the third case complicated with postoperative hepatic vein outflow obstruction,emergency hepatic vein outflow extending operation and assistant living donor liver transplantation were performed the next day,and finally died of liver and renal failure on the third day.Operation time（6.7 ± 0.47 h vs 13.7 ± 2.6 h） and anhepatic phase（3.5 ± 0.64 h vs 5.7 ± 1.7 h） were compared between Pichlmayr＇s group and our series（P = 0.78）.CONCLUSION：Ex-situ liver resection and liver autotransplantation has shown a potential for treatment of complicated hepatic neoplasms that are unresectable by traditional procedures. Liver autotransplantation Ex-situ resection Total vascular exclusion Liver tumor ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Correspondence to: Dr. Jia-Hong Dong, MD, Department of Hepatobiliary Surgery, General Hospital of Chinese People’s Liberation Army, Beijing 100853, China. dongjiahong301@126.com Author contributions: Zhang KM and Hu XW contributed equally to this work, performed the majority of this study and wrote the manuscript; Dong JH coordinated the study and revised the manuscript; Hong ZX, Wang ZH, Li GH, Qi RZ and Duan WD participated in the clinical work; and Zhang SG was also involved in revising the manuscript. Telephone: +86-10-66936037 Fax: +86-10-63946028 |
| PMID | 23326135 |
| PQID | 1273624618 |
| PQPubID | 23479 |
| PageCount | 6 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3544032 proquest_miscellaneous_1273624618 pubmed_primary_23326135 crossref_citationtrail_10_3748_wjg_v18_i48_7290 crossref_primary_10_3748_wjg_v18_i48_7290 chongqing_primary_44734771 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2012-12-28 |
| PublicationDateYYYYMMDD | 2012-12-28 |
| PublicationDate_xml | – month: 12 year: 2012 text: 2012-12-28 day: 28 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | World journal of gastroenterology : WJG |
| PublicationTitleAlternate | World Journal of Gastroenterology |
| PublicationYear | 2012 |
| Publisher | Baishideng Publishing Group Co., Limited |
| Publisher_xml | – name: Baishideng Publishing Group Co., Limited |
| References | 8156124 - J Am Coll Surg. 1994 Jan;178(1):79-82 17890866 - Eur Surg Res. 2008;40(1):41-6 715645 - Surg Gynecol Obstet. 1978 Nov;147(5):689-93 21999594 - HPB (Oxford). 2011 Nov;13(11):802-10 9607528 - Br J Surg. 1998 Apr;85(4):485-8 10857488 - Langenbecks Arch Surg. 2000 Apr;385(3):179-84 10819060 - Surgery. 2000 May;127(5):520-7 15650638 - Ann Surg. 2005 Feb;241(2):277-85 14607623 - Hepatobiliary Pancreat Dis Int. 2002 Feb;1(1):52-6 20454910 - J Hepatobiliary Pancreat Sci. 2010 Mar;17(2):197-202 1675751 - Lancet. 1991 Jun 29;337(8757):1616-7 15862260 - J Gastrointest Surg. 2005 May-Jun;9(5):658-66 18716829 - World J Surg. 2008 Nov;32(11):2403-7 1319257 - Br J Surg. 1992 Jun;79(6):566-7 12035042 - Ann Surg. 2002 Jun;235(6):850-8 21396305 - Am Surg. 2011 Jan;77(1):48-54 16794392 - Ann Surg. 2006 Jul;244(1):80-8 10749606 - Ann Surg. 2000 Apr;231(4):471-9 11677986 - Hepatogastroenterology. 2001 Sep-Oct;48(41):1455-60 14696489 - Hepatogastroenterology. 2003 Nov-Dec;50(54):2169-72 12081078 - J Am Coll Surg. 2002 Jun;194(6):842-5 8197568 - Surgery. 1994 Jun;115(6):740-4 16187182 - Dig Dis Sci. 2005 Oct;50(10):1829-35 12962846 - Transplant Proc. 2003 Aug;35(5):1913-4 2302506 - Br J Surg. 1990 Jan;77(1):21-6 |
| References_xml | – reference: 2302506 - Br J Surg. 1990 Jan;77(1):21-6 – reference: 15862260 - J Gastrointest Surg. 2005 May-Jun;9(5):658-66 – reference: 21999594 - HPB (Oxford). 2011 Nov;13(11):802-10 – reference: 10749606 - Ann Surg. 2000 Apr;231(4):471-9 – reference: 1675751 - Lancet. 1991 Jun 29;337(8757):1616-7 – reference: 715645 - Surg Gynecol Obstet. 1978 Nov;147(5):689-93 – reference: 15650638 - Ann Surg. 2005 Feb;241(2):277-85 – reference: 21396305 - Am Surg. 2011 Jan;77(1):48-54 – reference: 12081078 - J Am Coll Surg. 2002 Jun;194(6):842-5 – reference: 18716829 - World J Surg. 2008 Nov;32(11):2403-7 – reference: 10857488 - Langenbecks Arch Surg. 2000 Apr;385(3):179-84 – reference: 8156124 - J Am Coll Surg. 1994 Jan;178(1):79-82 – reference: 14696489 - Hepatogastroenterology. 2003 Nov-Dec;50(54):2169-72 – reference: 17890866 - Eur Surg Res. 2008;40(1):41-6 – reference: 12035042 - Ann Surg. 2002 Jun;235(6):850-8 – reference: 10819060 - Surgery. 2000 May;127(5):520-7 – reference: 11677986 - Hepatogastroenterology. 2001 Sep-Oct;48(41):1455-60 – reference: 14607623 - Hepatobiliary Pancreat Dis Int. 2002 Feb;1(1):52-6 – reference: 1319257 - Br J Surg. 1992 Jun;79(6):566-7 – reference: 16794392 - Ann Surg. 2006 Jul;244(1):80-8 – reference: 16187182 - Dig Dis Sci. 2005 Oct;50(10):1829-35 – reference: 8197568 - Surgery. 1994 Jun;115(6):740-4 – reference: 9607528 - Br J Surg. 1998 Apr;85(4):485-8 – reference: 20454910 - J Hepatobiliary Pancreat Sci. 2010 Mar;17(2):197-202 – reference: 12962846 - Transplant Proc. 2003 Aug;35(5):1913-4 |
| SSID | ssj0023352 |
| Score | 2.2232585 |
| Snippet | AIM：To evaluate the results of hepatic resection with ex-situ hypothermic perfusion and without veno-venous bypass.METHODS：In 3 patients with liver tumor,the... To evaluate the results of hepatic resection with ex-situ hypothermic perfusion and without veno-venous bypass. In 3 patients with liver tumor, the degree of... To evaluate the results of hepatic resection with ex-situ hypothermic perfusion and without veno-venous bypass.AIMTo evaluate the results of hepatic resection... AIM: To evaluate the results of hepatic resection with ex-situ hypothermic perfusion and without veno-venous bypass. METHODS: In 3 patients with liver tumor,... |
| SourceID | pubmedcentral proquest pubmed crossref chongqing |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 7290 |
| SubjectTerms | Brief Cholangiocarcinoma - surgery Female Hepatectomy - methods Hepatic Veins - surgery Humans Hypothermia, Induced Liver - surgery Liver Neoplasms - surgery Male Middle Aged Perfusion Postoperative Complications Retrospective Studies Tomography, X-Ray Computed Treatment Outcome Vena Cava, Inferior - surgery 原位 手术切除 操作时间 肝肿瘤 肝静脉 肾功能衰竭 肿瘤患者 自体移植 |
| Title | Ex-situ liver surgery without veno-venous bypass |
| URI | http://lib.cqvip.com/qk/84123X/201248/44734771.html https://www.ncbi.nlm.nih.gov/pubmed/23326135 https://www.proquest.com/docview/1273624618 https://pubmed.ncbi.nlm.nih.gov/PMC3544032 |
| Volume | 18 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9swDBaC7mUvw4Zd6Q54wPQwGEp9SJb0mDRug2IdsKFF82b4kFsXRdKtcXf8rP3CkbKdo-2GbUBi2KKoJB8ZiqIkipC3oZRZZErNcvBGGdcZZ1nhKVaUuS51mHvSbgo7_BBNjvnBVEx7vZ9rq5bqRTbIf9y5r-R_pAplIFfcJfsPkl02CgVwD_KFK0gYrn8l4_gbu6oWtXuBiyvcq2aHsw2t4mpjMGNzdt3kYM2-X6btUovWE6UxpyNFdURjSbWgapfGiqoQX3gT0KFnSZIqQWNBh2M6hMoR1WOkQsloD6nxHh3tUj20XCM68m2diCqJ7EpTpVZWnR1iaMJGqd0p4HLKTkzlTmr3oErZBM89Gs9thYpN0fRMmqd0ziZp5Z4g2z4-1Kn7vnI_1RVDovsRaKZilndco8lCln3TfdZ6bMO3x6wE6-YYA6ngYTZdsrFlAdhYqNQkebptw-sudWdrkWHw4K317vAo7uo5MAsPiPvr-eng2leDiqvBinMjHzfnMuQS0xbcCyT4a12EqB3k4x42O8PefvNmahyb37nZOKbzOANgPgPym27RrbHOzSW7az7Q0UPyoB28OMNGEx-Rnpk9Jl6rhY7VQqfVQqfVQmdNC51GC5-Q4734aHfC2nM4WB4qb8GM1GkYqqDUfhH5Sha-yaOM6zDKA1mCgwp08LuFFpkoUpGXCvM8KhNhtCyF91OyNZvPzHPiBKGRmS-N0IHPs4KnpvB4hNw6L6Qo-2R7CUly2eRbSTrE-2SnwyjJ2wz2eJDKRQIjWUQ4AYQTQDgBhBNEuE_eLTm61n5f900HewImFufN0pkBcBIfXPwI8y6qPnnWiGHZGsg7AI9Y9IncENCyAqZv36TMqjObxj0UnHthsP2nn_yC3F_9L16SrcWX2rwCL3iRvbZq9wuiU6QU |
| linkProvider | National Library of Medicine |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ex-situ+liver+surgery+without+veno-venous+bypass&rft.jtitle=%E4%B8%96%E7%95%8C%E8%83%83%E8%82%A0%E7%97%85%E5%AD%A6%E6%9D%82%E5%BF%97%EF%BC%9A%E8%8B%B1%E6%96%87%E7%89%88&rft.au=Ke-Ming+Zhang+Xiong-Wei+Hu+Jia-Hong+Dong+Zhi-Xian+Hong+Zhao-Hai+Wang+Gao-Hua+Li+Rui-Zhao+Qi+Wei-Dong+Duan+Shao-Geng+Zhang&rft.date=2012-12-28&rft.issn=1007-9327&rft.eissn=2219-2840&rft.volume=18&rft.issue=48&rft.spage=7290&rft.epage=7295&rft_id=info:doi/10.3748%2Fwjg.v18.i48.7290&rft.externalDocID=44734771 |
| thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F84123X%2F84123X.jpg |